Legal Press releases

2022-07-20 Legal Press releases

Intervacc receives order for Strangvac, a vaccine against the equine disease strangles, from the Dechra Pharmaceuticals PLC Group for launch in selected European countries

Stockholm, July 20th 2022 - Intervacc AB (publ) announces today that the company has received an order for the equivalent of approximately SEK 3 million from Dechra. The order concerns the delivery of ... Read more

2022-07-20 Legal Press releases

Strangvac, a vaccine against equine strangles released for sales in the UK

Stockholm, July 20th, 2022 - Intervacc AB (publ) announces today that the first batch of Strangvac^® for sale in the UK has been released.

Report from Annual General Meeting in Intervacc

Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Tuesday 14 June 2022, at which the following resolutions were made.

Adoption of the income statement and balance ... Read more

2022-05-31 Legal Press releases

Strangvac, a vaccine against equine strangles, available for sale in Denmark

Stockholm, May 31, 2022 - Intervacc announces today that Strangvac®, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.

Interim report January – March 2022

The period in summary

First quarter January 1 – March 31, 2022

On March 23 the first batch of Strangvac ... Read more

2022-05-19 Legal Press releases

Intervacc progresses vaccine to prevent mastitis in dairy cows caused by Staphylococcus aureus

Stockholm, May 19, 2022 - Intervacc AB (publ) announces the initiation of a proof-of-concept study to measure the effectiveness of a vaccine to protect dairy cows against mastitis caused by Staphylococcus ... Read more